MINERVINI, CRESCENZIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 2.796
EU - Europa 1.026
AS - Asia 324
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 4.150
Nazione #
US - Stati Uniti d'America 2.795
DE - Germania 409
CN - Cina 238
SE - Svezia 191
IT - Italia 111
GB - Regno Unito 100
RU - Federazione Russa 87
SG - Singapore 43
FI - Finlandia 35
FR - Francia 35
BE - Belgio 17
IN - India 14
UA - Ucraina 14
VN - Vietnam 13
CZ - Repubblica Ceca 12
IE - Irlanda 7
IQ - Iraq 3
AU - Australia 2
HK - Hong Kong 2
IR - Iran 2
JP - Giappone 2
KR - Corea 2
PL - Polonia 2
RO - Romania 2
TH - Thailandia 2
TR - Turchia 2
AT - Austria 1
BR - Brasile 1
BY - Bielorussia 1
GR - Grecia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NA - Namibia 1
Totale 4.150
Città #
Fairfield 454
Chandler 312
Woodbridge 253
Ashburn 234
Houston 198
Seattle 179
Nyköping 168
Cambridge 162
Wilmington 138
Ann Arbor 112
New York 103
Beijing 72
Bari 46
Lawrence 44
Jacksonville 43
Roxbury 41
Nanjing 34
Singapore 28
Brooklyn 26
Des Moines 26
Los Angeles 21
Redwood City 21
Falls Church 18
Marseille 18
Brussels 17
Princeton 17
Inglewood 16
Nanchang 16
San Diego 16
Boardman 14
Dong Ket 13
Guangzhou 13
Munich 12
Paris 10
Brno 9
Helsinki 9
Hebei 8
Changsha 7
London 7
Dearborn 6
Dublin 6
Shanghai 6
Tianjin 6
Jiaxing 5
Shenyang 5
Turi 5
Wuhan 5
Pune 4
Zhengzhou 4
Casamassima 3
Erbil 3
Hefei 3
Hounslow 3
Jinan 3
Milan 3
Olomouc 3
Triggiano 3
Washington 3
Bangkok 2
Brindisi 2
Fuzhou 2
Hong Kong 2
Hyderabad 2
Indiana 2
Kilburn 2
New Delhi 2
Ningbo 2
Padova 2
Pulsano 2
San Mateo 2
Southwark 2
Terni 2
Tiantai Chengguanzhen 2
Wuxi 2
Yiwu 2
Ashbourne 1
Avigliano 1
Berlin 1
Birmingham 1
Bisceglie 1
Bucharest 1
Böblingen 1
Chengdu 1
Corato 1
Daejeon 1
Dalian 1
Duncan 1
Genoa 1
Giovinazzo 1
Greenwich 1
Hamburg 1
Heze 1
Istanbul 1
Kraków 1
Leawood 1
Lecce 1
Mashhad 1
Melbourne 1
Miami 1
Monterrey 1
Totale 3.073
Nome #
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 160
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 160
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 157
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 136
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 133
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 130
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 124
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 122
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 121
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 120
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 116
null 115
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 111
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 110
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 101
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 101
MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene 100
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 99
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 99
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 99
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 97
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 96
null 94
Identification of novel LTR retrotransposons in the genome of Aedes aegypti 91
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 91
null 87
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 87
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 85
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 83
null 73
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 72
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 70
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 66
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 66
null 58
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 57
Epitranscriptomics in normal and malignant hematopoiesis 42
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities 37
Evidence of the physical interaction between rpl22 and the transposable element doc5, a heterochromatic transposon of drosophila melanogaster 37
The Ribosomal Protein RpL22 Interacts In Vitro with 5′-UTR Sequences Found in Some Drosophila melanogaster Transposons 36
Factors Affecting the Quality of Bacterial Genomes Assemblies by Canu after Nanopore Sequencing 36
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 33
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 32
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis 30
null 29
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 29
Identification and Characterisation of pST1023 A Mosaic, Multidrug-Resistant and Mobilisable IncR Plasmid 28
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation. 26
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 26
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 25
Heterochromatin protein 1 interacts with 5′UTR of transposable element ZAM in a sequence-specific fashion 25
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 23
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia 23
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter Of Diseases Or Prognostic Factors 19
Genome characterization and CRISPR-Cas9 editing of a human neocentromere 16
Altered gene expression encoding cytochines, grow factors and cell cycle regulators in the endometrium of women with chronic endometritis 16
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? 12
Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event 11
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective 8
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 7
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander? 7
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 5
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms 4
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis 4
Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements 2
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition? 2
Third-Generation Sequencing in Clinical Practice: The New Era of Precision Medicine? 1
null 1
Totale 4.319
Categoria #
all - tutte 16.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020898 0 33 55 101 106 79 85 104 124 96 64 51
2020/2021648 27 97 37 83 59 54 23 98 24 62 41 43
2021/2022410 30 33 5 10 16 39 18 37 34 36 61 91
2022/2023764 75 126 49 54 89 96 14 90 128 7 14 22
2023/2024424 26 53 20 29 42 149 10 15 1 15 11 53
2024/2025102 87 15 0 0 0 0 0 0 0 0 0 0
Totale 4.319